Gallbladder emptying during high-dose cholecystokinin infusions. Effect in patients with gallstone disease and healthy controls

Scand J Gastroenterol. 1995 Feb;30(2):128-32. doi: 10.3109/00365529509093250.

Abstract

Background: Impaired gallbladder emptying is a pathogenetic factor in gallstone formation. To test whether gallbladder motility can be improved by high-dose cholecystokinin (CCK), gallbladder emptying was measured sonographically in 21 patients with cholesterol gallstone disease and 6 healthy controls.

Methods: The effects of CCK infusions of 0.06 IDU/kg.min (group A, n = 11) and 0.12 IDU/kg.min (group B, n = 10) were compared with the response to a standard CCK infusion (0.02 IDU/kg.min). Controls received CCK at all infusion rates.

Results: The ejection fraction was smaller after CCK infusion of 0.06 IDU/kg.min than after the standard stimulus (group A, 52 +/- 10 versus 64 +/- 10%, p < 0.05; controls, 66 +/- 10 versus 91 +/- 3%, p < 0.05). After infusion of 0.12 IDU/kg.min CCK ejection fractions decreased even more (group B, 44 +/- 16 versus 65 +/- 12%, p < 0.05; controls, 54 +/- 12 versus 91 +/- 3%, p < 0.05). High-dose CCK infusions shortened the ejection period markedly, whereas the ejection rate remained unaltered.

Conclusions: High-dose CCK does not improve gallbladder motility but blocks the ejection process early, leading to reduced gallbladder emptying in gallstone patients and healthy subjects.

Publication types

  • Comparative Study

MeSH terms

  • Case-Control Studies
  • Cholecystokinin / administration & dosage
  • Cholecystokinin / pharmacology*
  • Cholelithiasis / chemistry
  • Cholelithiasis / diagnostic imaging
  • Cholelithiasis / physiopathology*
  • Cholesterol / analysis
  • Female
  • Gallbladder / diagnostic imaging
  • Gallbladder Emptying / drug effects*
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Ultrasonography

Substances

  • Cholecystokinin
  • Cholesterol